CatherineEilleenMadiganMD
Pediatric Hematology & Oncology • Cambridge, MAPediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Medical Director , Rare Disease Innovation Unit , Biogen
Dr. Madigan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Binney St
Building 9, 6th Floor
Cambridge, MA 02142- Is this information wrong?
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2002 - 2006
UPMC Children's Hospital of PittsburghResidency, Pediatrics, 1999 - 2002
Keck School of Medicine of the University of Southern CaliforniaClass of 1999
Certifications & Licensure
CA State Medical License 2002 - 2019
Publications & Presentations
PubMed
- 30 citationsPlacenta Growth Factor (PlGF), a Novel Inducer of Plasminogen Activator Inhibitor-1 (PAI-1) in Sickle Cell Disease (SCD)Nitin Patel, Nambirajan Sundaram, Mingyan Yang, Catherine Madigan, Vijay K. Kalra, Punam Malik> ;The Journal of Biological Chemistry. 2010 May 28
- 47 citationsExtracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.Catherine Madigan, Saro H. Armenian, Marcio H. Malogolowkin, Leo Mascarenhas> ;Cancer. 2007 Nov 1
- 38 citationsPathophysiology and therapy for haemoglobinopathies. Part II: thalassaemias.Fabrizia Urbinati, Catherine Madigan, Punam Malik> ;Expert Reviews in Molecular Medicine. 2006 May 9
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
